(Photo by Paul Hennessy/SOPA Images/LightRocket via Getty Images)
July 27, 2022 10:34 AM EDT
Coronavirus

Covid-19 roundup: Pfiz­er, BioN­Tech forge ahead with en­hanced vac­cine; Brii moves on an­ti­body to counter sub­vari­ants

Tyler Patchen

News Reporter

While Pfiz­er and BioN­Tech’s Covid-19 vac­cine has been one of the pri­ma­ry treat­ments so far in the pan­dem­ic, both com­pa­nies are still ad­just­ing and mak­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Bris­tol My­er­s' TYK2 in­hibitor suc­ceeds in pair of Phase 3 pso­ri­at­ic arthri­tis tri­als

A service from the Financial Times